ArticleBMC medical imaging2026
A rest-task fMRI study of spatial working memory in HIV-infected individuals across cognitive states.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundHIV-associated neurocognitive disorders (HAND) are common complications in HIV-infected individuals, and working memory impairment is one of the core features. Although combination antiretroviral therapy (cART) has reduced the incidence of severe HAND, mild HAND remains prevalent. This study aims to explore the functional brain characteristics related to working memory in HIV-infected individuals with different cognitive states using resting-state and task-based functional magnetic resonance imaging (fMRI), and to identify candidate imaging markers for early diagnosis and inform future intervention targeting.
methodsFifty-nine HIV-infected individuals (30 with cognitive integrity [CI], 29 with asymptomatic neurocognitive impairment [ANI]) and 37 healthy controls (HC) were enrolled. Resting-state and task-based fMRI were acquired. Task-fMRI was performed using a spatial working memory task to analyze brain activation, functional connectivity (FC), and reconfiguration efficiency of FC from rest to task. FC networks were constructed as ROI-ROI Pearson correlation matrices (Fisher z-transformed) and significant group differences were identified using network-based statistics. Pearson and Spearman correlation analyses were used to explore the relationships between reconfiguration efficiency and clinical/cognitive variables.
resultsHC showed better task performance than both HIV groups, and ANI exhibited the poorest accuracy. Compared with CI, ANI had significantly lower neurocognitive domain T-scores in memory, attention/working memory, and abstraction/executive function. In task-fMRI analyses, ANI showed decreased activation in the bilateral orbital middle frontal gyri and the left middle temporal gyrus, alongside increased activation in the left cerebellum crus I relative to CI. Whole-brain analyses demonstrated widespread FC increases in both HIV groups at rest and during the task compared with HC. Reconfiguration efficiency differed across groups and showed stage-related associations with immune and cognitive measures.
conclusionsCognitive impairment in virally suppressed HIV is accompanied by altered working-memory network engagement, with greater cortico-cerebellar involvement in ANI. While static whole-brain FC showed widespread increases but limited CI-ANI separation under stringent correction, altered rest-to-task FC reconfiguration efficiency was associated with immune indices and neurocognitive/behavioral performance, suggesting that this cross-state metric may serve as a candidate marker for HAND phenotyping and risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.